AIT is a national healthcare company providing toxicology laboratory services to compliance testing, forensics, and clinical clients nationwide
In 1990, Michael A. Evans, Ph.D. founded the American Institute of Toxicology (AIT Laboratories) with five employees and one goal: to provide superior analytical testing and research to professionals in the healthcare industry. Today, the company is a premier national healthcare company with an experienced and skilled staff of more than 450 employees including expert toxicologists, innovative scientists dedicated to production, research, and assay development, and a highly trained information solutions department. AIT specializes in compliance testing, forensic toxicology drug testing, and clinical laboratory testing.
Clientele includes leading reference laboratories, federal, state, and local law-enforcement agencies, corporations, government agencies, pharmaceutical firms, hospitals, physicians, medical examiners, attorneys, and courts of law. Facilities include a 40,000 square-foot building near the Indianapolis International Airport and a 90,000 square-foot business operations unit in the Woodland Corporate Park on the northwest side of Indianapolis.
AIT is a science-based, technology-driven company that is always pushing the envelope to meet the diverse needs of its clients. In 2011, AIT launched AIT Pathways®, a comprehensive suite of services for compliance monitoring and prescription drug testing to help healthcare practitioners customize their treatment plans and create better outcomes for their patients. AIT is among the first in the industry to offer tools such as Urine Baselines, GuideMed®, and the Patient Adherence Tool. In addition, AIT is one of only a handful of laboratories in the nation that is able to test for the synthetic drugs K2/Spice and bath salts.
AIT takes an active role in legislation and policy making to raise awareness about the role of compliance testing in combating prescription drug abuse. In 2010, AIT co-founded the Coalition for Excellence in Medication Monitoring (CEMM) to represent the legislative and policy-making interests of the compliance monitoring industry.
The company’s list of accolades includes multiple honors. AIT has been named to Inc. magazine’s list of the top 5,000 fastest-growing, private companies in the nation for five consecutive years. Training magazine has ranked AIT on its national list of the Top 125 for employer-sponsored training and development programs for two consecutive years. In 2009, AIT was named the "Small Business of the Year" by the Indiana Chamber of Commerce.
On July 1, 2009, Evans transferred ownership of the company to his employees in an Employee Stock Ownership Plan (ESOP).
AIT was the first private toxicology laboratory in North America to receive certification from the International Organization for Standardization (ISO), a federation of national-standards bodies concerned with consistent rules of technical specifications. AIT is also certified through the College of American Pathologists (CAP), Clinical Laboratory Improvement Amendments (CLIA), and American Board of Forensic Toxicology (ABFT).
AIT’s procedures comply with toxicology laboratory guidelines distributed by the American Board of Forensic Toxicology (ABFT), Society of Forensic Toxicologists (SOFT), the American Academy of Forensic Sciences (AAFS), and the International Association of Forensic Toxicologists (IAFT).
To learn more about AIT, click here.